Research field (3):
Experimental pathology
, Immunology
, Biomedical engineering
Research theme for competitive and other funds (3):
2022 - 2025 Creation of a lymphatic drug delivery system: controlling distant metastasis and immune-related adverse events
2021 - 2024 Development of innovative lymphatic drug delivery system for distant metastasis treatment
2020 - 2022 Development of a lymphatic drug delivery system to treat very early metastatic lymph nodes
Papers (29):
Takehiro Suzuki, Takuma Sato, Ariunbuyan Sukhbaatar, Maya Sakamoto, Shiro Mori, Tetsuya Kodama, Akihiro Ito. Ultrasound irradiation in the presence of microbubbles may enhance the antitumor effect of chemotherapeutic agents against bladder cancer. Journal of Cancer. 2025. 16. 2. 368-381
Koki Takagi, Ariunbuyan Sukhbaatar, Yohei Inaba, Shiro Mori, Tetsuya Kodama. A combination of lymphatic drug delivery of anti-CTLA-4 antibody and local radiotherapy for solid-tumor treatment. Cancer Science. 2024
Ariunbuyan Sukhbaatar, Shiro Mori, Tsuyoshi Sugiura, Tetsuya Kodama. Docetaxel administered through a novel lymphatic drug delivery system (LDDS) improved treatment outcomes for lymph node metastasis. Biomedicine & Pharmacotherapy. 2024. 171. 116085-116085
岩間 亮介, スフバートル・アリウンブヤン, 黒羽根 壮, 梶田 倫功, 纐纈 衆, 森 士朗, 小玉 哲也. CDDPによるリンパ行性がん化学療法における薬剤溶媒特性のリンパ節転移治療へ及ぼす影響(Efficacy of a Drug Delivery System Against Lymph Node Metastases with Physicochemically Modificated Cisplatin). 日本癌学会総会記事. 2023. 82回. 324-324
スフバートル・アリウンブヤン, 纐纈 衆, 宮下 仁, 森 士朗, 杉浦 剛, 小玉 哲也. リンパ行性薬剤送達法の開発のための諸臓器所解剖学的解析ンパネットワークマウスモデルの病理(Physioanatomical analysis of mouse lymphatic network for the lymphatic drug delivery system usage). 日本癌学会総会記事. 2023. 82回. 503-503
鈴木健大, 佐藤琢磨, アリウンブヤン スフバートル, 阪本真弥, 森士朗, 小玉哲也, 伊藤明宏. The combination of vesical instillation of chemotherapy with ultrasound and nanobubbles is efficient against experimental tumors in murine bladder cancer model. 日本泌尿器科学会総会(Web). 2023. 110th